What does Alchemich Farma do?

Alchemich Farma is registered with the CBE as active in: Vervaardiging van geneesmiddelen. Private Limited, started on 28 April 2008, 1 establishment.

What is the address of Alchemich Farma?

The registered office of Alchemich Farma is located at Stationsstraat 45, 3530 Houthalen-Helchteren.

Is Alchemich Farma still active?

Yes. According to the CBE (18 September 2026) Alchemich Farma is active, legal situation “Normale toestand”, started on 28 April 2008.

Is Alchemich Farma registered on Peppol?

Yes, Alchemich Farma is registered on the Peppol network with ID 0208:0897592963.

What is the enterprise number of Alchemich Farma?

The enterprise number of Alchemich Farma is BE0897592963.

When was Alchemich Farma founded?

Alchemich Farma was founded on 28 April 2008.

Who are the directors of Alchemich Farma?

According to the 2024 annual accounts, the directors of Alchemich Farma are: Jaak Gerits, Svetlana Smirnova.

Is Alchemich Farma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 April 2008; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did Alchemich Farma make in 2024?

Alchemich Farma recorded a loss after taxes of € 18,831 in financial year 2024.

What is the revenue of Alchemich Farma?

As a small company, Alchemich Farma is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 2,717.

Alchemich Farma (Private Limited) - Houthalen-Helchteren

Dossier Alchemich Farma, printed on 18 September 2026 from databakkes.be/en/0897592963/alchemich-farma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Alchemich Farma from Houthalen-Helchteren, company number BE0897592963, closed financial year 2024 with a result of € -18,831 after tax. For that financial year Alchemich Farma recorded a gross margin of € 2,717 and equity of € 8,498. Compared with financial year 2023, the result moved from € 2,155 to € -18,831. The company made a loss. The buffer shrank hard: equity is 69 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 4, 2025.

What it is worth Shrank hard

€ 8,498

▼ 69% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -18,831

▼ still € 2,155 profit in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 122,403

▲ € 120,705 vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -10,102.

People and assets in 2024

Vehicles and equipment

€ 39,987

▲ 1% vs 2023

Of which on lease € 32,105.

Debts at end 2024

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 23,974

▼ 21% vs 2023

€ 6,923 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 802

▼ 93% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,646

▲ 34% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 69,168 Gross margin 2021: € 69,168 First fiscal year in the series	€ 35,563 Gross margin 2022: € 35,563 ▼ 49% vs 2021 (€ 69,168) Unfavourable step	€ 19,795 Gross margin 2023: € 19,795 ▼ 44% vs 2022 (€ 35,563) Unfavourable step	€ 2,717 Gross margin 2024: € 2,717 ▼ 86% vs 2023 (€ 19,795) Unfavourable step	▼ 86%
Profit after taxes	€ 48,205 Profit after taxes 2021: € 48,205 First fiscal year in the series	€ 22,405 Profit after taxes 2022: € 22,405 ▼ 54% vs 2021 (€ 48,205) Unfavourable step	€ 2,155 Profit after taxes 2023: € 2,155 ▼ 90% vs 2022 (€ 22,405) Unfavourable step	€ -18,831 Profit after taxes 2024: € -18,831 ▼ € 20,986 vs 2023 (€ 2,155) Unfavourable step	▼ € 20,986
Equity	€ 62,769 Equity 2021: € 62,769 First fiscal year in the series	€ 25,173 Equity 2022: € 25,173 ▼ 60% vs 2021 (€ 62,769) Unfavourable step	€ 27,329 Equity 2023: € 27,329 ▲ 9% vs 2022 (€ 25,173) Favourable step	€ 8,498 Equity 2024: € 8,498 ▼ 69% vs 2023 (€ 27,329) Unfavourable step	▼ 69%
Total debts	€ 174,381 Total debts 2021: € 174,381 First fiscal year in the series	€ 103,708 Total debts 2022: € 103,708 ▼ 41% vs 2021 (€ 174,381) Favourable step	€ 197,508 Total debts 2023: € 197,508 ▲ 90% vs 2022 (€ 103,708) Unfavourable step	€ 239,446 Total debts 2024: € 239,446 ▲ 21% vs 2023 (€ 197,508) Unfavourable step	▲ 21%
Cash	€ 8,129 Cash 2021: € 8,129 First fiscal year in the series	€ 5,638 Cash 2022: € 5,638 ▼ 31% vs 2021 (€ 8,129) Unfavourable step	€ 1,698 Cash 2023: € 1,698 ▼ 70% vs 2022 (€ 5,638) Unfavourable step	€ 122,403 Cash 2024: € 122,403 ▲ € 120,705 vs 2023 (€ 1,698) Favourable step	▲ € 120,705
Retained profit	€ 44,169 Retained profit 2021: € 44,169 First fiscal year in the series	€ 6,573 Retained profit 2022: € 6,573 ▼ 85% vs 2021 (€ 44,169) Unfavourable step	€ 8,729 Retained profit 2023: € 8,729 ▲ 33% vs 2022 (€ 6,573) Favourable step	€ -10,102 Retained profit 2024: € -10,102 ▼ € 18,831 vs 2023 (€ 8,729) Unfavourable step	▼ € 18,831
Dividend	€ 125,000 Dividend 2021: € 125,000 First fiscal year in the series	€ 60,000 Dividend 2022: € 60,000 ▼ 52% vs 2021 (€ 125,000) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 60,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 30,362 Bank debt 2023: € 30,362 Unchanged (€ 0) Unfavourable step	€ 23,974 Bank debt 2024: € 23,974 ▼ 21% vs 2023 (€ 30,362) Favourable step	▼ 21%
Balance sheet total	€ 237,150 Balance sheet total 2021: € 237,150 First fiscal year in the series	€ 128,882 Balance sheet total 2022: € 128,882 ▼ 46% vs 2021 (€ 237,150) Unchanged	€ 224,837 Balance sheet total 2023: € 224,837 ▲ 74% vs 2022 (€ 128,882) Unchanged	€ 247,944 Balance sheet total 2024: € 247,944 ▲ 10% vs 2023 (€ 224,837) Unchanged	▲ 10%

Key figures of Alchemich Farma, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Alchemich Farma?

What happened at Alchemich Farma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 4, 2025 New annual accounts for financial year 2024: loss of € 18,831 (▼ € 20,986 vs 2023). Source: NBB ↗
Apr 28, 2008 New establishment in Houthalen-Helchteren. KBO
Apr 28, 2008 Start of the company according to the CBE. KBO

In short

From € 48,205 profit in 2021 to € 18,831 loss in 2024.

Paid € 33,333 in corporate taxes since 2021.

Best year ever: 2021, with € 48,205 profit.

Paid out € 185,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Alchemich Farma? We notify you, reason included.

Follow Alchemich Farma

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jaak Gerits Svetlana Smirnova

Alchemich Farma

Behind Alchemich Farma are Jaak Gerits and Svetlana Smirnova.

See the full network in the app

Directors

According to the 2024 annual accounts

Jaak Gerits

Director

Svetlana Smirnova

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 45

3530 Houthalen-Helchteren

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0897.592.963

VAT number

BE 0897.592.963

Registered office

Stationsstraat 45, 3530 Houthalen-Helchteren

Names & denominations

Alchemich Farma

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

28 April 2008

Peppol

Active · Active since 26 Jun 2025

Contact

+32495286822

Activities · NACE

Vervaardiging van geneesmiddelen

Detailhandel in cultuur- en recreatieartikelen, neg

Detailhandel in nieuwe kunstvoorwerpen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

Alchemich Farma

Financials

What happened to Alchemich Farma?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions